| Title |
Olanzapine for schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, April 2005
|
| DOI | 10.1002/14651858.cd001359.pub2 |
| Pubmed ID | |
| Authors |
Lorna Duggan, Mark Fenton, John Rathbone, Roland Dardennes, Ahmed El-Dosoky, Saroja Indran |
| Abstract |
Olanzapine is an atypical antipsychotic reported to be effective without producing disabling extrapyramidal adverse effects associated with older, typical antipsychotic drugs. |
Twitter Demographics
The data shown below were collected from the profiles of 15 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 13% |
| Canada | 1 | 7% |
| Chile | 1 | 7% |
| India | 1 | 7% |
| United Kingdom | 1 | 7% |
| Japan | 1 | 7% |
| Unknown | 8 | 53% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 73% |
| Practitioners (doctors, other healthcare professionals) | 3 | 20% |
| Scientists | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 274 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Chile | 1 | <1% |
| Sweden | 1 | <1% |
| United Kingdom | 1 | <1% |
| Singapore | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 269 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 44 | 16% |
| Researcher | 42 | 15% |
| Student > Bachelor | 22 | 8% |
| Student > Ph. D. Student | 16 | 6% |
| Student > Doctoral Student | 16 | 6% |
| Other | 68 | 25% |
| Unknown | 66 | 24% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 87 | 32% |
| Psychology | 33 | 12% |
| Nursing and Health Professions | 15 | 5% |
| Unspecified | 15 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 4% |
| Other | 36 | 13% |
| Unknown | 76 | 28% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 December 2020.
All research outputs
#1,327,788
of 22,713,403 outputs
Outputs from Cochrane database of systematic reviews
#3,054
of 12,313 outputs
Outputs of similar age
#1,832
of 57,869 outputs
Outputs of similar age from Cochrane database of systematic reviews
#11
of 46 outputs
Altmetric has tracked 22,713,403 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,313 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 57,869 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.